Delivery Order SPE2DB22D2007-SPE2DB25FJ0FX

Award Date 3/27/25
Potential Completion Date 4/17/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET, a medication, with a ceiling value of $4,156.56 and a completion date of June 3, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORGOVYX 120 MG TABLET, a medical product, with a ceiling value of $2,771.04 and an ultimate completion date of April 9, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, with a total ceiling value of $1,385.52 and a performance period through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.85, is for the supply of ORGOVYX 120 MG TABLET medical products. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,385.52 and has an ultimate completion date of March 10, 2025. The contract is for the procurement of ORGOVYX 120 MG TABLET, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ORGOVYX 120 MG Tablet, a pharmaceutical product, with a firm fixed price ceiling of $1,329.89 and a completion date of October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical and medical supplies distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ORGOVYX 120 MG TABLET, a prescription medication, at a ceiling value of $1,329.89. The contract has an ultimate completion date of July 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ORGOVYX 120 MG TABLET in 30-count packages. The contract is a firm-fixed-price delivery order with a ceiling value of $1,385.52 and a period of performance through April 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,771.04 firm fixed-price contract is for the supply of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a ceiling value of $1,375.85 and a period of performance through January 28, 2025. The contract is a firm-fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0FX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a ceiling value of $1,385.52 and a completion date of April 17, 2025.

The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. No subcontractors were identified in the information provided.

Generated 6/26/25, 10:13 AM